Imaging and photodynamic therapy: mechanisms, monitoring, and optimization

JP Celli, BQ Spring, I Rizvi, CL Evans… - Chemical …, 2010 - ACS Publications
The purpose of this review is to present the current state of the role of imaging in
photodynamic therapy (PDT). For the reader to fully appreciate the context of the discussions …

[HTML][HTML] Unique diagnostic and therapeutic roles of porphyrins and phthalocyanines in photodynamic therapy, imaging and theranostics

LB Josefsen, RW Boyle - Theranostics, 2012 - ncbi.nlm.nih.gov
Porphyrinic molecules have a unique theranostic role in disease therapy; they have been
used to image, detect and treat different forms of diseased tissue including age-related …

Bladder cancer: epidemiology, staging and grading, and diagnosis

Z Kirkali, T Chan, M Manoharan, F Algaba, C Busch… - Urology, 2005 - Elsevier
Bladder cancer is a heterogeneous disease with a variable natural history. At one end of the
spectrum, low-grade Ta tumors have a low progression rate and require initial endoscopic …

Photodynamic therapy in dentistry

K Konopka, T Goslinski - Journal of dental research, 2007 - journals.sagepub.com
Photodynamic therapy (PDT), also known as photoradiation therapy, phototherapy, or
photochemo-therapy, involves the use of a photoactive dye (photosensitizer) that is activated …

The history of photodetection and photodynamic therapy¶

R Ackroyd, C Kelty, N Brown… - Photochemistry and …, 2001 - Wiley Online Library
Light has been employed in the treatment of disease since antiquity. Many ancient
civilizations utilized phototherapy, but it was not until early last century that this form of …

Sensitive β-galactosidase-targeting fluorescence probe for visualizing small peritoneal metastatic tumours in vivo

D Asanuma, M Sakabe, M Kamiya, K Yamamoto… - Nature …, 2015 - nature.com
Fluorescence-guided diagnostics is one of the most promising approaches for facile
detection of cancer in situ. Here we focus on β-galactosidase, which is overexpressed in …

Hexyl aminolevulinate–guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non–muscle-invasive bladder cancer: a critical review of the …

M Rink, M Babjuk, JWF Catto, P Jichlinski, SF Shariat… - European urology, 2013 - Elsevier
Context Controversy exists regarding the therapeutic benefit and cost effectiveness of
photodynamic diagnosis (PDD) with 5-aminolevulinic acid (5-ALA) or hexyl aminolevulinate …

Photodynamic diagnosis in non–muscle-invasive bladder cancer: a systematic review and cumulative analysis of prospective studies

I Kausch, M Sommerauer, F Montorsi, A Stenzl… - European urology, 2010 - Elsevier
CONTEXT: The clinical benefit of photodynamic diagnosis (PDD) with 5-aminolevulinic acid
or hexaminolevulinate in addition to white-light cystoscopy (WLC) in bladder cancer has …

Photodynamic diagnosis of bladder cancer compared with white light cystoscopy: Systematic review and meta-analysis

G Mowatt, J N'Dow, L Vale, G Nabi… - International journal of …, 2011 - cambridge.org
Objectives: The aim of this study was to assess the test performance and clinical
effectiveness of photodynamic diagnosis (PDD) compared with white light cystoscopy (WLC) …

A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase …

Y Fradet, HB Grossman, L Gomella, S Lerner… - The Journal of …, 2007 - auajournals.org
Purpose: We compared hexaminolevulinate (Hexvix®) fluorescence cystoscopy with white
light cystoscopy for detecting carcinoma in situ. Materials and Methods: In this multicenter …